Tranilast enhances the effect of anticancer agents in osteosarcoma

Tranilast [N-(3′,4′-dimethoxycinnamoyl)-anthranilic acid], initially developed as an antiallergic drug, also exhibits a growth inhibitory effect on various types of cancer. Osteosarcoma is treated mainly with high-dose methotrexate, doxorubicin, cisplatin and ifosfamide; however, 20–30 % of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashima, Takayuki, Nagano, Satoshi, Setoguchi, Takao, Sasaki, Hiromi, Saitoh, Yoshinobu, Maeda, Shingo, Komiya, Setsuro, Taniguchi, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549073/
https://www.ncbi.nlm.nih.gov/pubmed/31059083
http://dx.doi.org/10.3892/or.2019.7150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549073/
https://www.ncbi.nlm.nih.gov/pubmed/31059083
http://dx.doi.org/10.3892/or.2019.7150

Ejemplares similares